Toll‐Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility
Open accessThe DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Toll‐like receptors (TLRs) are the important mediators of inflammatory pathways in the gut which play a major role in mediating the immune responses towards a wide variety of pathogen‐derived ligands and link adaptive immunity with the innate immunity. Numerous studies in different populations across the continents have reported on the significant roles of TLR gene polymorphisms in modulating the risk of colorectal cancer (CRC). CRC is one of the major malignancies affecting the worldwide population and is currently ranking the third most common cancer in the world. In this review, we have attempted to discuss the structure, functions, and signaling of TLRs in comprehensive detail together with the role played by various TLR gene SNPs in CRC susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pollutant-driven alterations in TLR recognition of pathogens may contribute to the increased susceptibility and severity of viral infections, as well as the pathogenesis of airway diseases like asthma.”
From Is Pollution the Primary Driver of Infectious Syndemics? (2024) · cites this paper as [45]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TLRs can be activated by pathogen-associated molecular patterns (PAMPs) (e.g., bacteria, viruses, or fungi) and DAMPs (e.g., protein aggregates, ATP, mtDNA).277”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [277]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952 · cited 6×
“Majority of the immune response elicited by the TLRs is due to the highly specific ectodomain containing a germ line encoded and highly conserved LRR region [18, 31, 53].”
BackgroundInfluentialThe role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304 · cited 6×
“Most of the PRRs after getting activated by the molecular patterns from the pathogens cause the upregulation of the inflammatory response gene especially proinflammatory cytokines and type I interferons [18, 35, 42].”
BackgroundInfluentialPattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895 · cited 14×
“TRIF-dependent pathway It is utilized by TLR3 and TLR4 to trigger the enhanced expression of interferon type-1 genes.”
BackgroundInfluentialAkira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312 · cited 1×
“For TLRs, various adaptor molecules have been identified which get recruited to the CTD domain of the activated and/or dimerized receptor to pass the signal downstream of the cell [31, 72, 73].”
BackgroundDefective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631 · cited 1×
“Some of the TLRs are highly specific in recognizing and binding to some particular ligands, like TLR2 for lipoproteins, lipotechoic acid (LTA), peptidoglycans (PG), zymosan and porin [65, 66], TLR3 for dsRNA derived from viruses [67], TLR4 for gram-negative bacteria-derived lipopolysaccharides (LPS) and plant-derived…”
BackgroundGenetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728 · cited 1×
“CRC initiation and progression follow a multigene and multistage genetic instability model called the Vogelstein model of carcinogenesis [12].”
MethodA Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 1×
“Some of the TLRs are highly specific in recognizing and binding to some particular ligands, like TLR2 for lipoproteins, lipotechoic acid (LTA), peptidoglycans (PG), zymosan and porin [65, 66], TLR3 for dsRNA derived from viruses [67], TLR4 for gram-negative bacteria-derived lipopolysaccharides (LPS) and plant-derived…”
BackgroundTakeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129 · cited 1×
“Some of the TLRs are highly specific in recognizing and binding to some particular ligands, like TLR2 for lipoproteins, lipotechoic acid (LTA), peptidoglycans (PG), zymosan and porin [65, 66], TLR3 for dsRNA derived from viruses [67], TLR4 for gram-negative bacteria-derived lipopolysaccharides (LPS) and plant-derived…”
BackgroundA human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590 · cited 1×
“In humans, TLR4 was the first of the TLR family to be discovered and reported to regulate the inflammatory responses [59], while TLR3 is the most ancient one which belongs to the viral TLRs like TLR7-9 [35, 53].”
BackgroundDekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32319-0 · Cited by 4,974
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777 · cited 2×
“CRC is one of the malignancies in which inflammation is considered as the pivotal risk factor [10, 23], coupled with the key role TLRs play in the inflammation-driven carcinogenesis [5, 6, 15, 16, 29, 53, 95]; targeting various TLRs with the various agonists, antagonist, and vaccine adjuvants is being currently explor…”
BackgroundLemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.-M., & Hoffmann, J. A. (1996) · Cell · doi:10.1016/s0092-8674(00)80172-5 · Cited by 4,043
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., Eng, J. K., Akira, S., Underhill, D. M., & Aderem, A. (2001) · Nature · doi:10.1038/35074106 · Cited by 3,601
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711 · cited 1×
“numerous proinflammatory molecules including interleukin- (IL-) 1b, tumor necrosis factor a (TNFa), and IL-6 [18, 31, 79–81]; while on the other hand, it leads to the increased expression of many antiapoptotic genes in addition to the restriction of proapoptotic pathways mediated by c-Jun kinase [82, 83].”
BackgroundSmall anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,522 · cited 1×
“Some of the TLRs are highly specific in recognizing and binding to some particular ligands, like TLR2 for lipoproteins, lipotechoic acid (LTA), peptidoglycans (PG), zymosan and porin [65, 66], TLR3 for dsRNA derived from viruses [67], TLR4 for gram-negative bacteria-derived lipopolysaccharides (LPS) and plant-derived…”
BackgroundToll-like Receptors and the Control of Immunity
Fitzgerald, K. A., & Kagan, J. C. (2020) · Cell · doi:10.1016/j.cell.2020.02.041 · Cited by 2,168 · cited 3×
“To date, 222 TLRs have been identified in invertebrates and 28 TLRs in vertebrates, with the highest number of TLRs in an individual found in the vertebrate fish of teleost which possesses 21 TLR molecules—TLR1-5, TLR7-9, TLR13-14, TLR18-23, and TLR25-28 [35, 42, 48, 55, 57, 58] (Table 1).”
BackgroundTLR4 mutations are associated with endotoxin hyporesponsiveness in humans
Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024 · cited 3×
“ALRs: AIM2-like receptors AP1: Activator protein 1 BCAP: B-cell adaptor for phosphoinositide CLRs: C-type lectin receptors CTD: C-terminal domain DAMPs: Damage/danger-associated molecular patterns DKs: Dendritic cells IFN: Interferon IKK: IκB kinase IRAK: IL-1R-associated kinase IRF-3: Interferon regulatory factor-3 L…”
BackgroundAutophagy in infection, inflammation and immunity
Deretic, V., Saitoh, T., & Akira, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3532 · Cited by 1,919 · cited 1×
“In addition, PRR signaling also leads to the triggering of various processes involved in autophagy, cell death, cytokine processing, and phagocytosis [40, 41].”
BackgroundTumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2
Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., & Kirschning, C. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17406 · Cited by 1,704 · cited 1×
“Some of the TLRs are highly specific in recognizing and binding to some particular ligands, like TLR2 for lipoproteins, lipotechoic acid (LTA), peptidoglycans (PG), zymosan and porin [65, 66], TLR3 for dsRNA derived from viruses [67], TLR4 for gram-negative bacteria-derived lipopolysaccharides (LPS) and plant-derived…”
BackgroundInnate Immune Pattern Recognition: A Cell Biological Perspective
Brubaker, S. W., Bonham, K. S., Zanoni, I., & Kagan, J. C. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112240 · Cited by 1,475 · cited 1×
“In addition, PRR signaling also leads to the triggering of various processes involved in autophagy, cell death, cytokine processing, and phagocytosis [40, 41].”
BackgroundGlobal cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Intestinal Inflammation and Cancer
Ullman, T. A., & Itzkowitz, S. H. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.057 · Cited by 1,119
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Diamond, M. S., Kinder, M., Matsushita, H., Mashayekhi, M., Dunn, G. P., Archambault, J. M., Lee, H., Arthur, C. D., White, J. M., Kalinke, U., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101158 · Cited by 1,081 · cited 1×
“On activation, DCs exert their effective modulating role on the key effectors like NKs and CTLs in a type I interferon-dependent manner [74, 76].”
BackgroundTargeting Toll-like receptors: emerging therapeutics?
Hennessy, E. J., Parker, A. E., & O'Neill, L. A. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3203 · Cited by 886
Assembly and localization of Toll-like receptor signalling complexes
Gay, N. J., Symmons, M. F., Gangloff, M., & Bryant, C. E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3713 · Cited by 832 · cited 2×
“In their active signal-transducing form, they exist as dimers—TLR1-TLR2, TLR2-TLR6, and TLR2TLR4/5/10 [60] (2) Intracellular TLRs, which are expressed within the host cells on the organelle biomembranes like endoplasmic reticulum (ER), endosomes, and lysosomes.”
BackgroundToll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages
Underhill, D. M., Ozinsky, A., Smith, K. D., & Aderem, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14459 · Cited by 827 · cited 1×
“Some of the TLRs are highly specific in recognizing and binding to some particular ligands, like TLR2 for lipoproteins, lipotechoic acid (LTA), peptidoglycans (PG), zymosan and porin [65, 66], TLR3 for dsRNA derived from viruses [67], TLR4 for gram-negative bacteria-derived lipopolysaccharides (LPS) and plant-derived…”
BackgroundLeucine-rich repeats and pathogen recognition in Toll-like receptors
Bell, J. K., Mullen, G. E. D., Leifer, C. A., Mazzoni, A., Davies, D. R., & Segal, D. M. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00242-4 · Cited by 762 · cited 2×
“N-terminal domain makes up an ectodomain to serve as the ligand recognition site to the variety of PAMP, while CTD is involved in the interactions with various signal transduction adaptors for the initiation of downstream signaling through its toll-IL-1 receptor (TIR) homologous domain [18, 35, 42, 48, 50].”
BackgroundRecognition and Signaling by Toll-Like Receptors
West, A. P., Koblansky, A. A., & Ghosh, S. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.115827 · Cited by 720 · cited 7×
“Because of their ability to recognize and bind with a wide variety of PAMPs (bacteria, parasites, fungi, and viruses) and DAMPs, they act as important regulators of the immune responses and bridge the innate with adaptive immune responses in the host [20, 31, 35, 52, 63, 85].”
BackgroundInfluentialThe Structural Biology of Toll-like Receptors
Botos, I., Segal, D. M., & Davies, D. R. (2011) · Structure · doi:10.1016/j.str.2011.02.004 · Cited by 693 · cited 2×
“The ectodomain has a folded solenoid structure (resembling a horseshoe) of about 19-25 highly conserved short tandem leucine-rich repeat (LRR) motifs, which provide the muchneeded specificity and recognizability to the TLRs for PAMPs/DAMPs [36, 51].”
BackgroundGenetic alterations in colorectal cancer.
Armaghany, T., Wilson, J. D., Chu, Q., & Mills, G. M. (2012) · Europe PMC (PubMed Central) · Cited by 673
Structure and Function of Toll Receptors and Their Ligands
Gay, N. J., & Gangloff, M. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.151318 · Cited by 667 · cited 8×
“Because of their ability to recognize and bind with a wide variety of PAMPs (bacteria, parasites, fungi, and viruses) and DAMPs, they act as important regulators of the immune responses and bridge the innate with adaptive immune responses in the host [20, 31, 35, 52, 63, 85].”
BackgroundInfluentialToll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay, K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.002 · Cited by 643
Anderson, K. V., Bokla, L., & Nüsslein-Volhard, C. (1985) · Cell · doi:10.1016/0092-8674(85)90275-2 · Cited by 621 · cited 1×
“The discovery of the TLR receptors dates to the identification and functional characterization of the toll gene and its protein in Drosophila [43].”
BackgroundTLR Signaling in the Gut in Health and Disease
Abreu, M. T., Fukata, M., & Arditi, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4453 · Cited by 581 · cited 1×
“CRC is one of the malignancies in which inflammation is considered as the pivotal risk factor [10, 23], coupled with the key role TLRs play in the inflammation-driven carcinogenesis [5, 6, 15, 16, 29, 53, 95]; targeting various TLRs with the various agonists, antagonist, and vaccine adjuvants is being currently explor…”
BackgroundToll-like receptors — taking an evolutionary approach
Leulier, F., & Lemaitre, B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2303 · Cited by 581 · cited 3×
“To date, 222 TLRs have been identified in invertebrates and 28 TLRs in vertebrates, with the highest number of TLRs in an individual found in the vertebrate fish of teleost which possesses 21 TLR molecules—TLR1-5, TLR7-9, TLR13-14, TLR18-23, and TLR25-28 [35, 42, 48, 55, 57, 58] (Table 1).”
BackgroundInflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
Grivennikov, S. I., & Karin, M. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.140145 · Cited by 560
Toll-like receptors activation, signaling, and targeting: an overview
El-Zayat, S. R., Sibaii, H., & Mannaa, F. A. (2019) · Bulletin of the National Research Centre · doi:10.1186/s42269-019-0227-2 · Cited by 556
Lim, K.-H., & Staudt, L. M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011247 · Cited by 469
Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals
Vidya, M. K., Kumar, V. G., Sejian, V., Bagath, M., Krishnan, G., & Bhatta, R. (2018) · International Reviews of Immunology · doi:10.1080/08830185.2017.1380200 · Cited by 442
Accessory molecules for Toll-like receptors and their function
Lee, C. C., Avalos, A. M., & Ploegh, H. L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3151 · Cited by 439 · cited 12×
“Because of their ability to recognize and bind with a wide variety of PAMPs (bacteria, parasites, fungi, and viruses) and DAMPs, they act as important regulators of the immune responses and bridge the innate with adaptive immune responses in the host [20, 31, 35, 52, 63, 85].”
BackgroundInfluentialImmunotherapy of cancer in 2012
Kirkwood, J. M., Butterfield, L. H., Tarhini, A. A., Zarour, H., Kalinski, P., & Ferrone, S. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20132 · Cited by 436 · cited 2×
“The dual effects help in the activation of antitumorigenic dendritic cells, cytotoxic T lymphocytes, and natural killer cells which play an active role in the suppression of oncogenic signaling pathways ([51, 74, 75, 122]; ).”
BackgroundTakeda, K., & Akira, S. (2015) · Current Protocols in Immunology · doi:10.1002/0471142735.im1412s109 · Cited by 421 · cited 8×
“Because of their ability to recognize and bind with a wide variety of PAMPs (bacteria, parasites, fungi, and viruses) and DAMPs, they act as important regulators of the immune responses and bridge the innate with adaptive immune responses in the host [20, 31, 35, 52, 63, 85].”
BackgroundInfluentialCurrent insights into the regulation of programmed cell death by NF-κB
Dutta, J., Fan, Y., Gupta, N., Fan, G., & Gélinas, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209938 · Cited by 407 · cited 1×
“numerous proinflammatory molecules including interleukin- (IL-) 1b, tumor necrosis factor a (TNFa), and IL-6 [18, 31, 79–81]; while on the other hand, it leads to the increased expression of many antiapoptotic genes in addition to the restriction of proapoptotic pathways mediated by c-Jun kinase [82, 83].”
BackgroundTakeda, K., & Akira, S. (2007) · Current Protocols in Immunology · doi:10.1002/0471142735.im1412s77 · Cited by 378
Gao, W., Xiong, Y., Li, Q., & Yang, H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00508 · Cited by 353 · cited 4×
“A recent advance in therapeutics has exploited both agonists and antagonists in a bid to develop an effective and long-lasting therapy for CRC [23, 51, 125].”
BackgroundInfluentialTLR agonists: our best frenemy in cancer immunotherapy
Kaczanowska, S., Joseph, A. M., & Davila, E. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012501 · Cited by 339 · cited 1×
“Usually, there are two chief strategies which are utilized in cancer therapeutics in achieving the TLR inhibition as follows: (a) preventing the ligand binding to the TLR receptor and (b) impeding the function of various proteins located downstream of the TLR signaling [23, 51, 122, 124, 125].”
BackgroundThe Yin and Yang of Toll-like receptors in cancer
Pradere, J.-P., Dapito, D. H., & Schwabe, R. F. (2014) · Oncogene · doi:10.1038/onc.2013.302 · Cited by 331 · cited 10×
“TLR2 rs5743708 SNP occurs in the TIR domain of the TLR2 and has been found to result in the impaired NF-κB signaling and decreased secretion of cytokines in response to the PAMPs [89].”
BackgroundInfluentialStructural Biology of the Toll-Like Receptor Family
Kang, J. Y., & Lee, J.-O. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052909-141507 · Cited by 331
Toll-Like Receptors, Associated Biological Roles, and Signaling Networks in Non-Mammals
Nie, L., Cai, S.-Y., Shao, J.-Z., & Chen, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01523 · Cited by 329
Schneider, D. S., Hudson, K. L., Lin, T. Y., & Anderson, K. V. (1991) · Genes & Development · doi:10.1101/gad.5.5.797 · Cited by 325 · cited 1×
“TLRs received their name because of their similarity to the toll protein in serving as the cell surface receptors [44], which play a role in providing the immunity against the fungal and gram-positive bacterial infections [45] together with their role in embryonic development and dorsoventral polarization [35, 46–49]).”
BackgroundInflammation by remote control
Mantovani, A. (2005) · Nature · doi:10.1038/435752a · Cited by 313
Microbiota, Inflammation and Colorectal Cancer
Lucas, C., Barnich, N., & Nguyen, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061310 · Cited by 313 · cited 2×
“CRC is one of the malignancies in which inflammation is considered as the pivotal risk factor [10, 23], coupled with the key role TLRs play in the inflammation-driven carcinogenesis [5, 6, 15, 16, 29, 53, 95]; targeting various TLRs with the various agonists, antagonist, and vaccine adjuvants is being currently explor…”
BackgroundMechanisms and pathways of innate immune activation and regulation in health and cancer
Cui, J., Chen, Y., Wang, H. Y., & Wang, R.-F. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/21645515.2014.979640 · Cited by 309 · cited 3×
“With the advent of technology and easy sequencing techniques, several studies have demonstrated the existence of numerous genetic polymorphisms affecting almost all TLR genes which have influence on the immune responses of the host towards the pathogenic infection or the consequent PAMPs and DAMPs [19, 22, 85, 89, 94].”
BackgroundDe Palma, M., Mazzieri, R., Politi, L. S., Pucci, F., Zonari, E., Sitia, G., Mazzoleni, S., Moi, D., Venneri, M. A., Indraccolo, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.09.004 · Cited by 301 · cited 1×
“Additionally, TLRinduced expression of alpha IFNs is known to limit tumorigenesis by suppressing the angiogenesis [77, 78].”
Background[Genetic alterations in colorectal cancer].
Laurent‐Puig, P. (1994) · PubMed · Cited by 293
Versican—A Critical Extracellular Matrix Regulator of Immunity and Inflammation
Wight, T. N., Kang, I., Evanko, S. P., Harten, I. A., Chang, M. Y., Pearce, O. M. T., Allen, C. E., & Frevert, C. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00512 · Cited by 268 · cited 1×
“Also, within the tumor microenvironment, there is an increased expression and secretion of versican, a large ECM proteoglycan, which is an important component of tissue inflammation as a result of infection or injury [84].”
BackgroundToll-Like Receptors: General Molecular and Structural Biology
Behzadi, P., García-Perdomo, H. A., & Karpiński, T. M. (2021) · Journal of Immunology Research · doi:10.1155/2021/9914854 · Cited by 251 · cited 11×
“Most of the PRRs after getting activated by the molecular patterns from the pathogens cause the upregulation of the inflammatory response gene especially proinflammatory cytokines and type I interferons [18, 35, 42].”
BackgroundInfluentialToll‐like receptor polymorphism in host immune response to infectious diseases: A review
Mukherjee, S., Huda, S., & Sinha Babu, S. P. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12771 · Cited by 250 · cited 9×
“Both are key inflammatory molecules playing a direct role in inflammatory pathways of CRC carcinogenesis [28, 89].”
BackgroundInfluentialMolecular mechanisms of regulation of Toll-like receptor signaling
Leifer, C. A., & Medvedev, A. E. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2mr0316-117rr · Cited by 247 · cited 1×
“For TLRs, various adaptor molecules have been identified which get recruited to the CTD domain of the activated and/or dimerized receptor to pass the signal downstream of the cell [31, 72, 73].”
BackgroundIs interleukin‐1 a good or bad ‘guy’ in tumor immunobiology and immunotherapy?
Apte, R. N., & Voronov, E. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00615.x · Cited by 239
Wang, E. L., Qian, Z. R., Nakasono, M., Tanahashi, T., Yoshimoto, K., Bando, Y., Kudo, E., Shimada, M., & Sano, T. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605558 · Cited by 238
Polymorphisms in Toll-like receptor genes and risk of cancer
El-Omar, E. M., Ng, M. T., & Hold, G. L. (2008) · Oncogene · doi:10.1038/sj.onc.1210912 · Cited by 233 · cited 3×
“Numerous studies have linked the dysregulation of the TLR expression to the colorectal carcinogenesis [16, 26, 27, 96–100], and now, the evidence is mounting for the role of genetic polymorphisms in modulating the risk of CRC in various populations as well [17, 19, 21, 22, 24, 28, 49, 89, 94].”
BackgroundImportant aspects of Toll-like receptors, ligands and their signaling pathways
Chang, Z. L. (2010) · Inflammation Research · doi:10.1007/s00011-010-0208-2 · Cited by 223 · cited 14×
“Because of their ability to recognize and bind with a wide variety of PAMPs (bacteria, parasites, fungi, and viruses) and DAMPs, they act as important regulators of the immune responses and bridge the innate with adaptive immune responses in the host [20, 31, 35, 52, 63, 85].”
BackgroundInfluentialEvolutionary Origins of Toll-like Receptor Signaling
Brennan, J. J., & Gilmore, T. D. (2018) · Molecular Biology and Evolution · doi:10.1093/molbev/msy050 · Cited by 223
Ospelt, C., & Gay, S. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.10.010 · Cited by 197
Toll-like receptors and chronic inflammation in rheumatic diseases: new developments
Joosten, L. A. B., Abdollahi-Roodsaz, S., Dinarello, C. A., O'Neill, L., & Netea, M. G. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.61 · Cited by 195
Role of Toll-like receptors in gastrointestinal malignancies
Fukata, M., & Abreu, M. T. (2008) · Oncogene · doi:10.1038/sj.onc.1210908 · Cited by 178 · cited 1×
“CRC is one of the malignancies in which inflammation is considered as the pivotal risk factor [10, 23], coupled with the key role TLRs play in the inflammation-driven carcinogenesis [5, 6, 15, 16, 29, 53, 95]; targeting various TLRs with the various agonists, antagonist, and vaccine adjuvants is being currently explor…”
BackgroundImmunité naturelle: Structure et fonction des Toll-like receptors
Delneste, Y., Beauvillain, C., & Jeannin, P. (2007) · médecine/sciences · doi:10.1051/medsci/200723167 · Cited by 176
Colorectal Cancer: Molecular Mutations and Polymorphisms
Sameer, A. S. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00114 · Cited by 171 · cited 3×
“CRC is one of the malignancies in which inflammation is considered as the pivotal risk factor [10, 23], coupled with the key role TLRs play in the inflammation-driven carcinogenesis [5, 6, 15, 16, 29, 53, 95]; targeting various TLRs with the various agonists, antagonist, and vaccine adjuvants is being currently explor…”
BackgroundSingle nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases
Skevaki, C., Pararas, M., Kostelidou, K., Tsakris, A., & Routsias, J. G. (2015) · Clinical and Experimental Immunology · doi:10.1111/cei.12578 · Cited by 169 · cited 9×
“Because of their ability to recognize and bind with a wide variety of PAMPs (bacteria, parasites, fungi, and viruses) and DAMPs, they act as important regulators of the immune responses and bridge the innate with adaptive immune responses in the host [20, 31, 35, 52, 63, 85].”
BackgroundInfluentialThe ABC of clinical and experimental adjuvants—A brief overview
Brunner, R., Jensen‐Jarolim, E., & Pali‐Schöll, I. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.10.005 · Cited by 165 · cited 1×
“CRC is one of the malignancies in which inflammation is considered as the pivotal risk factor [10, 23], coupled with the key role TLRs play in the inflammation-driven carcinogenesis [5, 6, 15, 16, 29, 53, 95]; targeting various TLRs with the various agonists, antagonist, and vaccine adjuvants is being currently explor…”
BackgroundToll-like receptor–mediated activation of neutrophils by influenza A virus
Wang, J. P., Bowen, G. N., Padden, C., Cerny, A., Finberg, R. W., Newburger, P. E., & Kurt-Jones, E. A. (2008) · Blood · doi:10.1182/blood-2008-01-132860 · Cited by 162
Toll-Like Receptor Polymorphisms, Inflammatory and Infectious Diseases, Allergies, and Cancer
Medvedev, A. E. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0140 · Cited by 162 · cited 2×
“Numerous studies have linked the dysregulation of the TLR expression to the colorectal carcinogenesis [16, 26, 27, 96–100], and now, the evidence is mounting for the role of genetic polymorphisms in modulating the risk of CRC in various populations as well [17, 19, 21, 22, 24, 28, 49, 89, 94].”
BackgroundTrial Watch: Toll-like receptor agonists for cancer therapy
Vacchelli, E., Eggermont, A., Sautès-Fridman, C., Galon, J., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2013) · OncoImmunology · doi:10.4161/onci.25238 · Cited by 154
Lowe, E. L., Crother, T. R., Rabizadeh, S., Hu, B., Wang, H., Chen, S., Shimada, K., Wong, M. H., Michelsen, K. S., & Arditi, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013027 · Cited by 148
PRR-signaling pathways: Learning from microbial tactics
Sellge, G., & Kufer, T. A. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.009 · Cited by 145
Toll-like receptor signaling in colorectal cancer: Carcinogenesis to cancer therapy
Li, T.-T., Ogino, S., & Qian, Z. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17699 · Cited by 145
Intrinsic and Extrinsic Regulation of Innate Immune Receptors
Jeong, E., & Lee, J. Y. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2011.52.3.379 · Cited by 131
Regulation of innate immune responses by transmembrane interactions: Lessons from the TLR family
Reuven, E. M., Fink, A., & Shai, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.01.020 · Cited by 129 · cited 2×
“Depending upon their functionality and location in the host cell, TLRs are further categorized into two types [18, 35, 38, 48, 56] as follows:”
BackgroundKutikhin, A. G. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.07.307 · Cited by 124 · cited 8×
“In the TLR4 gene, two polymorphisms have been identified to play a role in the CRC tumorigenesis risk [19, 22, 89].”
BackgroundInfluentialTargeting Toll-Like Receptors for Cancer Therapy
Braunstein, M. J., Kucharczyk, J. R., & Adams, S. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0589-7 · Cited by 122 · cited 3×
“CRC is one of the malignancies in which inflammation is considered as the pivotal risk factor [10, 23], coupled with the key role TLRs play in the inflammation-driven carcinogenesis [5, 6, 15, 16, 29, 53, 95]; targeting various TLRs with the various agonists, antagonist, and vaccine adjuvants is being currently explor…”
BackgroundToll-like receptors as therapeutic targets for autoimmune connective tissue diseases
Li, J., Wang, X., Zhang, F., & Yin, H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.003 · Cited by 121
Pattern Recognition Receptors in Cancer Progression and Metastasis
Pandey, S., Singh, S. P., Anang, V., Bhatt, A. N., Natarajan, K., & Dwarakanath, B. S. R. (2015) · Cancer Growth and Metastasis · doi:10.4137/cgm.s24314 · Cited by 106
Slattery, M. L., Herrick, J. S., Bondurant, K. L., & Wolff, R. K. (2012) · International Journal of Cancer · doi:10.1002/ijc.26314 · Cited by 103 · cited 3×
“Numerous studies have linked the dysregulation of the TLR expression to the colorectal carcinogenesis [16, 26, 27, 96–100], and now, the evidence is mounting for the role of genetic polymorphisms in modulating the risk of CRC in various populations as well [17, 19, 21, 22, 24, 28, 49, 89, 94].”
BackgroundToll-Like Receptor 4 in Inflammation and Angiogenesis: A Double-Edged Sword
Murad, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00313 · Cited by 100 · cited 4×
“Similarly, TLRs also do bind with various endogenous ligands (host-derived DAMPs) like plasma membrane constituents, heat shock proteins (HSPs), and organelle nucleic acids like mitochondrial DNA (mt DNA) [64].”
BackgroundInfluentialMicrosatelite GT polymorphism in the toll‐like receptor 2 is associated with colorectal cancer
Boraska Jelavić, T., Barišić, M., Drmic Hofman, I., Boraska, V, Vrdoljak, E., Peruzović, M., Hozo, I., Puljiz, Ž., & Terzić, J. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00651.x · Cited by 100 · cited 1×
“[106] found the unique microsatellite GT repeat polymorphism in the intronic region of the TLR2 gene to be associated with the CRC in the Croatian population.”
BackgroundAssociation of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility
Noreen, M., & Arshad, M. (2015) · Immunologic Research · doi:10.1007/s12026-015-8640-6 · Cited by 100 · cited 4×
“Numerous studies have linked the dysregulation of the TLR expression to the colorectal carcinogenesis [16, 26, 27, 96–100], and now, the evidence is mounting for the role of genetic polymorphisms in modulating the risk of CRC in various populations as well [17, 19, 21, 22, 24, 28, 49, 89, 94].”
BackgroundInfluentialStructures and recognition modes of toll‐like receptors
Gao, D., & Li, W. (2016) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25179 · Cited by 89 · cited 2×
“TLRs are predominantly expressed in the host antigenprocessing cells (APCs) which play crucial roles in recognizing the pathogenic infection and deciding their fate [62, 63].”
BackgroundSlattery, M. L., & Fitzpatrick, F. A. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0191 · Cited by 86 · cited 2×
“CRC is one of the malignancies in which inflammation is considered as the pivotal risk factor [10, 23], coupled with the key role TLRs play in the inflammation-driven carcinogenesis [5, 6, 15, 16, 29, 53, 95]; targeting various TLRs with the various agonists, antagonist, and vaccine adjuvants is being currently explor…”
BackgroundYim, J.-J., Ding, L., Schäffer, A. A., Park, G. Y., Shim, Y.-S., & Holland, S. M. (2004) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00342-0 · Cited by 78 · cited 2×
“Based on the repeat structure, three different alleles have been categorized: (GT)16 or less as S, (GT)17-22 as M, and (GT)23 or more as L allele, and are present in different populations in different frequencies [107].”
BackgroundIdentification and characteristic analysis of TLR28: A novel member of the TLR1 family in teleost
Wang, Y., Li, J., Han, J., Shu, C., & Xu, T. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.05.001 · Cited by 75 · cited 2×
“To date, 222 TLRs have been identified in invertebrates and 28 TLRs in vertebrates, with the highest number of TLRs in an individual found in the vertebrate fish of teleost which possesses 21 TLR molecules—TLR1-5, TLR7-9, TLR13-14, TLR18-23, and TLR25-28 [35, 42, 48, 55, 57, 58] (Table 1).”
BackgroundTLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer
Castro, F. A., Försti, A., Buch, S., Kalthoff, H., Krauss, C., Bauer, M., Egberts, J. H., Schniewind, B., Broering, D., Schreiber, S., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.12.011 · Cited by 74 · cited 1×
“Additionally, TLR3 rs3775291 was reported to be associated with CRC-specific survival, with patients having TT genotype having a 93% increased risk of death in comparison to CC ones [110].”
Pimentel‐Nunes, P., Teixeira, A. L., Pereira, C., Gomes, M. P., Brandão, C., Rodrigues, C., Gonçalves, N., Boal‐Carvalho, I., Roncon‐Albuquerque, R., Moreira‐Dias, L., et al. (2012) · Digestive and Liver Disease · doi:10.1016/j.dld.2012.08.006 · Cited by 70 · cited 1×
“[27] reported that TLR2 (+597T/C, rs3804099) resulted in a fivefold decreased risk of CRC.”
BackgroundFunctional TLR5 Genetic Variants Affect Human Colorectal Cancer Survival
Klimosch, S. N., Försti, A., Eckert, J., Knežević, J., Bevier, M., von Schönfels, W., Heits, N., Walter, J., Hinz, S., Lascorz, J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1746 · Cited by 68 · cited 1×
“[118] reported that these two TLR5 SNPs did disparately affect the risk of CRC with rs2072493 being associated with worse survival while rs5744174 with better survival.”
BackgroundAlejandra Trejo-de la, O., Hernández-Sancén, P., & Maldonado‐Bernal, C. (2014) · Genes and Immunity · doi:10.1038/gene.2014.10 · Cited by 64 · cited 11×
“Because of their ability to recognize and bind with a wide variety of PAMPs (bacteria, parasites, fungi, and viruses) and DAMPs, they act as important regulators of the immune responses and bridge the innate with adaptive immune responses in the host [20, 31, 35, 52, 63, 85].”
BackgroundInfluentialInfluence of Toll‐Like Receptor Gene Polymorphisms to Tuberculosis Susceptibility in Humans
Thada, S., Valluri, V. L., & Gaddam, S. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12066 · Cited by 63 · cited 1×
“TLR9 is a unique receptor for the unmethylated DNA derivatives from the viruses and bacteria [24, 92].”
BackgroundXu, H., Wu, Q., Dang, S., Jin, M., Xu, J., Cheng, Y., Pan, M., Wu, Y., Zhang, C., & Zhang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027399 · Cited by 55
Tissue expression of Toll-like receptors 2 and 4 in sporadic human colorectal cancer
Nihonyanagi, Y., Terai, K., Murano, T., Matsumoto, T., & Okazumi, S. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1085-4 · Cited by 54
Expression and Functional Research of TLR4 in Human Colon Carcinoma
Tang, X., Wang, H., Zhu, Y., & Wei, B. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181cef1b7 · Cited by 52
Association of TLR2 and TLR4 Polymorphisms with Risk of Cancer: A Meta-Analysis
Zhu, L., Yuan, H., Jiang, T., Wang, R., Ma, H., & Zhang, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082858 · Cited by 51 · cited 4×
“[105] had reported that a significant association was found between the TLR2 −196 to −174 del and cancer risk; however, it was restricted to only a subgroup of Caucasian and south Asians and not among east Asians, while Proenca et al.”
BackgroundInfluentialMessaritakis, I., Stogiannitsi, M., Koulouridi, A., Sfakianaki, M., Voutsina, A., Sotiriou, A., Athanasakis, E., Xynos, E., Mavroudis, D., Tzardi, M. N., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197327 · Cited by 50 · cited 1×
“Of all the present SNPs in the TLR4 gene, two nonsynonymous SNPs (+896A/G, rs4986790 and +1196C/T, rs4986791) located within the exon 3 of a gene are known to induce substitution of amino acids Asp299Gly and Thr399Ile, respectively [97, 112, 113].”
BackgroundControversial role of toll-like receptors in acute pancreatitis
Vaz, J. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i5.616 · Cited by 43
Toll-like receptor signalling and their therapeutic targeting in colorectal cancer
Moossavi, S., & Rezaei, N. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.03.017 · Cited by 43 · cited 2×
“A recent advance in therapeutics has exploited both agonists and antagonists in a bid to develop an effective and long-lasting therapy for CRC [23, 51, 125].”
BackgroundKopp, T. I., Vogel, U. B., Tjønneland, A. M., & Andersen, V. C. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqx011 · Cited by 43 · cited 1×
“In addition, a recent study in the Danish population did implicate the TLR4 and TLR2 and their interaction with the meat-rich diet with the CRC risk [116].”
BackgroundDavoodi, H., & Seow, H. F. (2011) · PubMed · Cited by 42
TLR2andTLR4polymorphisms influence mRNA and protein expression in colorectal cancer
Proença, M. A., de Oliveira, J. G., Cadamuro, A. C. T., Succi, M., Netinho, J. G., Goloni-Bertolo, E. M., Pavarino, É. C., & Silva, A. E. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7730 · Cited by 42 · cited 7×
“This GV has been reported to cause the reduction in the transcription resulting in the reduced expression of the receptors in the cell [5, 105].”
BackgroundInfluentialBiologic activities of natural and synthetic type I interferons.
Pfeffer, L. M. (1997) · PubMed · Cited by 41
Fűri, I. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i26.4119 · Cited by 39 · cited 1×
“Although the increased expression of TLR9 has been reported in the advanced CRC [120, 121], its two SNPs—TLR9 rs187084 and rs352140—have lately been found to be associated with the inflammatory diseases which are regarded as the risk factor for CRC as well [19, 28].”
BackgroundToll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in cancer: A meta-analysis
Jing, J., Li, M., & Yuan, Y. (2012) · Gene · doi:10.1016/j.gene.2012.03.045 · Cited by 35
Omrane, I., Baroudi, O., Kourda, N., Bignon, Y., Uhrhammer, N. A., Desrichard, A., Medimegh, I., Ayari, H., Stambouli, N., Mézlini, A., et al. (2013) · Tumor Biology · doi:10.1007/s13277-013-1075-6 · Cited by 34 · cited 1×
“modulating the risk of CRC extensively [17, 21, 22, 25, 28, 49, 101, 102].”
Toll‐like receptors in prostate infection and cancer between bench and bedside
Gambara, G., Cesaris, P. D., Nunzio, C. D., Ziparo, E., Tubaro, A., Filippini, A., & Riccioli, A. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12055 · Cited by 32
TLR9 signaling activation at different stages in colorectal cancer and NF-kappaB expression
Gao, C., Qiao, T., Zhang, B., Yuan, S., Zhuang, X., & Luo, Y. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s174274 · Cited by 32 · cited 1×
“Although the increased expression of TLR9 has been reported in the advanced CRC [120, 121], its two SNPs—TLR9 rs187084 and rs352140—have lately been found to be associated with the inflammatory diseases which are regarded as the risk factor for CRC as well [19, 28].”
BackgroundTLR3 gene polymorphisms in cancer: a systematic review and meta-analysis
Wang, B.-G., Yi, D., & Liu, Y. (2015) · 癌症:英文版 · doi:10.1186/s40880-015-0020-z · Cited by 27 · cited 2×
“About 10 SNPs have been reported to span an entire coding region of the TLR3 gene, and among these five SNPs, rs5743305, rs11721827, rs3775290, rs3775291, and rs3775292 have been extensively studied and reported to modulate the risk of cancers including CRC [17, 109].”
Backgroundsheng, W. Y., Zhang, Y., Yun, Z., Hong, H., & Hai, L. L. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.53288 · Cited by 25
Infection, inflammation and colon carcinogenesis
Wogan, G. N., Dedon, P. C., Tannenbaum, S. R., & Fox, J. G. (2012) · Oncotarget · doi:10.18632/oncotarget.624 · Cited by 24
Role of Toll-Like Receptor 4 in Colorectal Carcinogenesis: A Meta-Analysis
Li, X., Sun, G., Meng, J., Li, X., Tang, Y., Li, Z., Wang, M., Liang, G.-F., & Lu, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093904 · Cited by 23 · cited 2×
“Numerous studies and meta-analyses have linked TLR4 SNPs with the increased risk of CRC [22, 86, 113, 115].”
BackgroundYoshida, T., Miura, T., Matsumiya, T., Yoshida, H., Morohashi, H., Sakamoto, Y., Kurose, A., Imaizumi, T., & Hakamada, K. (2020) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s252157 · Cited by 15
Mutations and Polymorphisms: What Is The Difference?
Aga, S. S., Banday, M. Z., & Nissar, S. (2021) · Springer eBooks · doi:10.1007/978-981-33-6699-2_1 · Cited by 15 · cited 1×
“SNPs in any gene results in the change of amino acid sequence (missense/frameshift) which alters the structure and activity of the involved protein [103].”
BackgroundSelf-citationProfile of gene expression of TLR-signaling pathways in colorectal cancer tissues
Bednarczyk, M., Muc‐Wierzgoń, M., Walkiewicz, K. W., Kokot, T., Fatyga, E., & Mazurek, U. M. (2017) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632017716048 · Cited by 14
Moaaz, M., Youssry, S., Moaz, A., & Abdelrahman, M. (2020) · Immunological Investigations · doi:10.1080/08820139.2020.1716787 · Cited by 14 · cited 2×
“[115] reported that both these SNPs are associated with the risk of CRC in the Egyptian population.”
BackgroundToll-like receptor genetic variants and colorectal cancer
Weber, A. N. R., & Försti, A. (2014) · OncoImmunology · doi:10.4161/onci.27763 · Cited by 12 · cited 5×
“The rs5744174 SNP leads to the substitution of leucine to phenylalanine at 616 amino acid residues of TLR5, thereby affecting the ligand recognition capacity of the receptor, contributing to the increased inflammation and hence increase the risk of cancers [19, 28].”
BackgroundInfluentialNissar, S., Aga, S. S., Rasool, R., Qadri, Q., Chowdri, N. A., & Rashid, F. (2016) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2016.04.004 · Cited by 11
Self-citationUnderstanding Epigenetics: an Alternative Mechanism of Colorectal Carcinogenesis
Aga, S. S., & Nissar, S. (2016) · Current Colorectal Cancer Reports · doi:10.1007/s11888-016-0317-6 · Cited by 7 · cited 1×
“Currently, three pathways for the genetic instability have been identified for the CRC initiation, development, and progression which are as follows: chromosomal instability (CIN) pathway, microsatellite instability (MSI) pathway, and CpG island methylator phenotype (CIMP) pathway [11, 13, 14].”
BackgroundSelf-citationHosseini, S., Mojtahedi, Z., Beizavi, Z., Khazraei, H., & Zamani, M. (2018) · Archives of Biological Sciences · doi:10.2298/abs180812043h · Cited by 6 · cited 1×
“modulating the risk of CRC extensively [17, 21, 22, 25, 28, 49, 101, 102].”
Colorectal Cancer and Genetic Polymorphism in Key Regulatory Low Penetrance Genes
Banday, M. Z., Aga, S. S., & Nissar, S. (2021) · Springer eBooks · doi:10.1007/978-981-33-6699-2_5 · Cited by 2 · cited 3×
“Numerous gene mutations (suppressing and activating), gene silencing, and genetic polymorphisms have been shown to play their role in driving the carcinogenesis pathway, with each stage having a unique molecular fingerprint of genetic variations [10, 11].”
BackgroundSelf-citation
Research works printed but not linked: 2
- Ferlay J., 2018, Cancer today (powered by GLOBOCAN 2018), IARC Cancer Base number
- 10.1051/medsci/20072316 · doi:10.1051/medsci/20072316
Cited by
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“, protein aggregates, ATP, mtDNA).(277) TLR activation leads to receptor dimerization and the recruitment of adapter proteins, such as Toll/interleukin 1 receptor (TIR) domain-containing adapter interferon-β (TRIF) and myeloid differentiation primaryresponse protein 88 (MyD88)(276) (Fig.”
BackgroundFornari Laurindo, L., Aparecido Dias, J., Cressoni Araújo, A., Torres Pomini, K., Machado Galhardi, C., Rucco Penteado Detregiachi, C., Santos de Argollo Haber, L., Donizeti Roque, D., Dib Bechara, M., Vialogo Marques de Castro, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305933 · Cited by 144
“Meanwhile, the CTD participates in interactions with various signal transduction adaptors, initiating downstream signaling through its toll-IL-1 receptor (TIR) homologous domain (219).”
BackgroundMukherjee, S., Patra, R., Behzadi, P., Masotti, A., Paolini, A., & Sarshar, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1244345 · Cited by 166
Kaur, H., & Ali, S. A. (2022) · Food & Function · doi:10.1039/d2fo00911k · Cited by 135
The role of p53 in anti-tumor immunity and response to immunotherapy
Carlsen, L., Zhang, S., Tian, X., De La Cruz, A., George, A., Arnoff, T. E., & El-Deiry, W. S. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1148389 · Cited by 100
“TLR3, 5, 7, 8, and 9 are primarily involved in the innate immune response and trigger type I interferon (IFN) synthesis through IFN regulatory factors (IRFs) (Sameer and Nissar, 2021).”
Background
Metadata
- Authors
- Sameer, A. S., & Nissar, S.
- Affiliations
- Government Medical College (IN)
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2021-01
- Volume
- 2021
- Issue
- 1
- Pages
- 1157023-1157023
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC8452412
- OpenAlex
- W3200104592
- Cited by
- 323
- References
- 128
- Citations by year
- 2026: 41 · 2025: 90 · 2024: 101 · 2023: 62 · 2022: 29
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- Toll-like receptors, colorectal cancer, genetic polymorphism, single nucleotide polymorphisms, Toll-like receptor signaling, innate immunity, intestinal inflammation, cancer susceptibility
- MeSH terms
- Humans, Ligands, Polymorphism, Genetic, Colorectal Neoplasms, Signal Transduction, Genetic Predisposition to Disease, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



